Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma
Abstract Comprehensive analysis of clinical samples has recently identified molecular and immunological classification of hepatocellular carcinoma (HCC), and the CTNNB1 (β-catenin)-mutated subtype exhibits distinctive characteristics of immunosuppressive tumor microenvironment. For clarifying the mo...
Guardado en:
Autores principales: | Masafumi Akasu, Shu Shimada, Ayano Kabashima, Yoshimitsu Akiyama, Masahiro Shimokawa, Keiichi Akahoshi, Atsushi Kudo, Shoji Yamaoka, Minoru Tanabe, Shinji Tanaka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/63c7a6b15ee74a9d819e44b8f20fa851 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
por: Franciscus C. Vermeer, et al.
Publicado: (2021) -
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
por: Tomohiko Yamamura, et al.
Publicado: (2020) -
Machine learning based CRISPR gRNA design for therapeutic exon skipping.
por: Wilson Louie, et al.
Publicado: (2021) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
por: Gang Han, et al.
Publicado: (2016) -
Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy
por: Pablo Beckers, et al.
Publicado: (2021)